SHANGHAI JUNSHI BIOSCIENCES CO LTD revenue breakdown overview

SHANGHAI JUNSHI BIOSCIENCES CO LTD revenue for the last year amounted to 1.95 B CNY, the most of which — 1.95 B CNY — came from its highest performing source at the moment, Innovative Drugs, the year earlier bringing 1.50 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought SHANGHAI JUNSHI BIOSCIENCES CO LTD 1.85 B CNY, and the year before that — 1.16 B CNY.